3.4(top 4%)
Impact Factor
3.8(top 4%)
extended IF
136(top 2%)
citing journals
citing authors

Most Cited Articles of Clinical Therapeutics

A systematic review of the associations between dose regimens and medication compliance20011.7K
Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice1999605
Recognition and treatment of hyponatremia in acutely ill hospitalized patients2007551
Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity2000487
Capecitabine: a review2005451
Immunogenicity of therapeutic proteins: clinical implications and future prospects2002433
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study2006431
Evaluating quality-of-life and health status instruments: development of scientific review criteria1996431
The cost of treating community-acquired pneumonia1998420
Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies2006388
Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir2001356
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma2015353
Childhood obesity: a review of increased risk for physical and psychological comorbidities2013348
Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer1999341
Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials2003332
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study2007326
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation2015314
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group2000314
A review of the chemistry, biological action, and clinical applications of anabolic-androgenic steroids2001301
Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study2008294
Current Challenges in Cancer Treatment2016293
Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability2004282
A review of diabetes treatment adherence and the association with clinical and economic outcomes2011277
Predictors of medication adherence in the elderly1998276
Lapatinib: a dual inhibitor of human epidermal growth factor receptor tyrosine kinases2008270